Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
amlodipine | carbonic anhydrase 1 | small molecule | NA | drugbank | Coronary Arteriosclerosis[MeSHID:D003324] Hypertensive disease[MeSHID:D006973] Disease[MeSHID:D004194] Coronary heart disease[MeSHID:D003327] Heart failure[MeSHID:D006333] Stable angina[MeSHID:D060050] Angina Pectoris Variant[MeSHID:D000788] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
amlodipine | voltage-dependent n-type calcium channel subunit alpha-1b | small molecule | NA | drugbank , DGIDB | Coronary Arteriosclerosis[MeSHID:D003324] Hypertensive disease[MeSHID:D006973] Disease[MeSHID:D004194] Coronary heart disease[MeSHID:D003327] Heart failure[MeSHID:D006333] Stable angina[MeSHID:D060050] Angina Pectoris Variant[MeSHID:D000788] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
1.52 | approved | inhibitor |
amlodipine | voltage-dependent n-type calcium channel | small molecule | NA | drugbank , DGIDB | Coronary Arteriosclerosis[MeSHID:D003324] Hypertensive disease[MeSHID:D006973] Disease[MeSHID:D004194] Coronary heart disease[MeSHID:D003327] Heart failure[MeSHID:D006333] Stable angina[MeSHID:D060050] Angina Pectoris Variant[MeSHID:D000788] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
1.52 | approved | inhibitor |
amlodipine | voltage-dependent l-type calcium channel subunit alpha-1c | small molecule | NA | drugbank , DGIDB | Coronary Arteriosclerosis[MeSHID:D003324] Hypertensive disease[MeSHID:D006973] Disease[MeSHID:D004194] Coronary heart disease[MeSHID:D003327] Heart failure[MeSHID:D006333] Stable angina[MeSHID:D060050] Angina Pectoris Variant[MeSHID:D000788] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.62 | approved | inhibitor |
amlodipine | voltage-dependent t-type calcium channel subunit alpha-1i | small molecule | NA | drugbank | Coronary Arteriosclerosis[MeSHID:D003324] Hypertensive disease[MeSHID:D006973] Disease[MeSHID:D004194] Coronary heart disease[MeSHID:D003327] Heart failure[MeSHID:D006333] Stable angina[MeSHID:D060050] Angina Pectoris Variant[MeSHID:D000788] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
amlodipine | voltage-gated calcium channel alpha-2/delta-1 | NA | Successful target | TTD , DGIDB | Coronary Arteriosclerosis[MeSHID:D003324] Hypertensive disease[MeSHID:D006973] Disease[MeSHID:D004194] Coronary heart disease[MeSHID:D003327] Heart failure[MeSHID:D006333] Stable angina[MeSHID:D060050] Angina Pectoris Variant[MeSHID:D000788] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.88 | approved | unknown |
amlodipine | voltage-dependent calcium channel subunit alpha-2/delta-3 | small molecule | NA | drugbank | Coronary Arteriosclerosis[MeSHID:D003324] Hypertensive disease[MeSHID:D006973] Disease[MeSHID:D004194] Coronary heart disease[MeSHID:D003327] Heart failure[MeSHID:D006333] Stable angina[MeSHID:D060050] Angina Pectoris Variant[MeSHID:D000788] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
amlodipine | voltage-dependent l-type calcium channel subunit beta-1 | small molecule | NA | drugbank | Coronary Arteriosclerosis[MeSHID:D003324] Hypertensive disease[MeSHID:D006973] Disease[MeSHID:D004194] Coronary heart disease[MeSHID:D003327] Heart failure[MeSHID:D006333] Stable angina[MeSHID:D060050] Angina Pectoris Variant[MeSHID:D000788] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
amlodipine | sphingomyelin phosphodiesterase | small molecule | NA | drugbank | Coronary Arteriosclerosis[MeSHID:D003324] Hypertensive disease[MeSHID:D006973] Disease[MeSHID:D004194] Coronary heart disease[MeSHID:D003327] Heart failure[MeSHID:D006333] Stable angina[MeSHID:D060050] Angina Pectoris Variant[MeSHID:D000788] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
click here to return to the previous page |